patient outcomes

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial

Study Overview The study aimed to evaluate the effectiveness and safety of mirikizumab, a monoclonal antibody targeting the IL-23 pathway,

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial Read Post »

Physiatry Reviews for Evidence in Practice (PREP) Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist: “Context of Injury and Clinical Trajectories After Mild Traumatic Brain Injury”

Study Overview The research investigated the outcomes and clinical trajectories following mild traumatic brain injury (mTBI), with a specific focus

Physiatry Reviews for Evidence in Practice (PREP) Second-Order Peer Reviews of Clinically Relevant Articles for the Physiatrist: “Context of Injury and Clinical Trajectories After Mild Traumatic Brain Injury” Read Post »

Scroll to Top